Kamyar Hadian
- Molecular Biology top 2%
- Pulmonary and Respiratory Medicine top 1%
- Cancer Research top 1%
- Immunology top 5%
- Oncology top 5%
- Co-authors
- Brent R. StockwellKenji SchorppDaniel KrappmannIna RothenaignerNataša AnastasovStefanie M. HauckSebastian BrandnerPhilippe Schmitt‐Kopplin
- Topics
- RNA modifications and cancer (11 papers)Ubiquitin and proteasome pathways (10 papers)Ferroptosis and cancer prognosis (9 papers)
- Partner nations
- GermanyUnited StatesUnited Kingdom
In The Last Decade
Kamyar Hadian
75 papers receiving 4.2k citations
Hit Papers
Peers
Comparison fields: 5 of 118
- Molecular Biology 2.7k
- Pulmonary and Respiratory Medicine 1.7k
- Cancer Research 1.6k
- Immunology 526
- Oncology 514
Countries citing papers authored by Kamyar Hadian
This map shows the geographic impact of Kamyar Hadian's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Kamyar Hadian with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Kamyar Hadian more than expected).
Fields of papers citing papers by Kamyar Hadian
This network shows the impact of papers produced by Kamyar Hadian. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Kamyar Hadian. The network helps show where Kamyar Hadian may publish in the future.
Co-authorship network of co-authors of Kamyar Hadian
This figure shows the co-authorship network connecting the top 25 collaborators of Kamyar Hadian. A scholar is included among the top collaborators of Kamyar Hadian based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Kamyar Hadian. Kamyar Hadian is excluded from the visualization to improve readability, since they are connected to all nodes in the network.
All Works
| # | Work | Indexed citations |
|---|---|---|
| 1 | 23 | |
| 2 | 6 | |
| 3 | 2 | |
| 4 | 1 | |
| 5 | 5 | |
| 6 | 0 | |
| 7 | 2 | |
| 8 | 33 | |
| 9 | 24 | |
| 10 | 26 | |
| 11 | 15 | |
| 12 | 2 | |
| 13 | 27 | |
| 14 | 45 | |
| 15 | Innovative therapeutic modalities for solid EpCAM-positive tumours | 1 |
| 16 | 22 | |
| 17 | 4 | |
| 18 | 5 | |
| 19 | 11 | |
| 20 | 186 |
About Kamyar Hadian
Kamyar Hadian is a scholar working on Biophysics, Cancer Research and Virology, having authored 78 papers that have together received 4.2k indexed citations. Recurring topics across this work include RNA modifications and cancer (11 papers), Ubiquitin and proteasome pathways (10 papers) and Ferroptosis and cancer prognosis (9 papers). The work is most often cited by research in Cancer Research (1.6k citations), Pulmonary and Respiratory Medicine (1.7k citations) and Molecular Biology (2.7k citations). Kamyar Hadian has collaborated with scholars based in Germany, United States and United Kingdom. Frequent co-authors include Brent R. Stockwell, Kenji Schorpp, Daniel Krappmann, Ina Rothenaigner, Nataša Anastasov, Stefanie M. Hauck, Sebastian Brandner, Philippe Schmitt‐Kopplin, Constanze Müller and Fereshteh Zandkarimi. Their work appears in journals such as Science, Cell and Journal of Biological Chemistry.
Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.